Continuing Medical Education
School of Medicine, UAB
   
Course Catalog
Back to Online Courses
Online CME Courses
Treatment of Hyperlipidemia


Certified for 1 AMA PRA Category 1 Credit


Co-Sponsored by the University of Alabama School of Medicine
Division of Continuing Medical Education and
The Alabama Quality Assurance Foundation

Release Date: July 14, 2005
Expiration Date: July 14, 2008

TARGET AUDIENCE:
Primary care physicians

OBJECTIVES:
Upon completion of this CME activity, clinicians should be able to:
  • To review current evidence supporting the treatment of hyperlipidemia
  • To review the different classes of agents that can be used to treat hyperlipidemia
  • To understand the indications for combination therapy
  • To identify some of the common side effects from the different treatment options
Top of Page

SOURCE:
FACULTY:

Martin Rodriguez, MD
Clinical Fellow in Infectious Diseases
Massachusetts General Hospital

Top of Page

DISCLOSURE:
Dr. Rodriguez has no commercial affiliations to disclose.
Top of Page

CME PARTICIPATION:
To participate in this program for CME credit, please review the objectives before beginning the program. Take the course, complete the case questions and evaluation before July 14, 2008 to receive CME credit. Your certificate will then be available online. This process should take approximately 60 minutes.

ACCREDITATION:

The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Alabama School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The boards of nursing in many states, including Alabama, recognize Category 1 continuing medical education courses as acceptable activities for the renewal of license to practice nursing.

Top of Page

DISCLAIMER: 
Dosages, indications, and methods of use of any drug referred to in this online course may reflect the clinical experience of the authors, clinical literature, or other clinical resources. Therefore, please see the full prescribing information before using any product mentioned.

Case 1:

A 42-year-old female has a cardiorespiratory arrest in an airport. She is found to have ventricular fibrillation and is successfully resuscitated and transferred to a coronary care unit. She has a large ST-elevation anterior myocardial infarction and undergoes successful angioplasty and stenting. Her family history is positive for early coronary artery disease in her father and two brothers. She has been diagnosed in the past with hypertension but is not taking medications. Her lipid profile on admission reveals a total cholesterol of 232 mg/dL, HDL-cholesterol of 38 mg/dL, LDL-cholesterol of 168 mg/dL and triglycerides of 130 mg/dL. She is now hemodynamically stable and recovering.

Top of Page

Case 1, Question 1 of 6

1. Based on current evidence, which of the following therapeutic strategies for dyslipidemia seems to be the most appropriate for this patient?

A. Therapeutic lifestyle changes (TLC) alone
B. TLC and pravastatin 40 mg/day
C. TLC and gemfibrozil 600 mg bid
D. TLC and atorvastatin 80 mg/day



Refer to Friend Refer to Friend